T1 mapping shows promise for assessing neuroblastoma
The common MRI technique called T1 mapping -- typically used for patients with...Read more on AuntMinnie.comRelated Reading:
Imaging shows new, post-SARS-CoV-2 illness in children
Preop MRI finds 11% more cancer in women with DCIS
PET, MRI uncover women's predisposition to Alzheimer's
Imaging reveals baby girl in SC born with 2nd mouth
Caution indicated with new GBCAs for kidney patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 1, 2020 Category: Radiology Source Type: news
New radioisotope works better for certain cancers
A new radiopharmaceutical has shown better imaging performance in tumor detection,...Read more on AuntMinnie.comRelated Reading:
New radioisotope therapy treats pediatric neuroblastoma
Groups ask NRC to allow virtual radiotracer training
New tau PET tracer better targets source of Alzheimer's
Navidea touts phase IIB study looking at RA
New PET/CT tracer reliably detects prostate cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 29, 2020 Category: Radiology Source Type: news
New radioisotope therapy treats pediatric neuroblastoma
Japanese researchers have discovered a new radioisotope therapy for children...Read more on AuntMinnie.comRelated Reading:
Researchers link brain tumor treatment to GBCA deposition
AJR paper describes errors in pediatric radiography
Whole-body MRI has mixed results in pediatric cancer patients
Dell donates cloud cluster for pediatric cancer trial
Protocols protect pediatric caregivers from I-131 exposure (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 22, 2020 Category: Radiology Source Type: news
A novel radioisotope therapy for children with neuroblastoma
(Kanazawa University) Researchers from Kanazawa University retrospectively analyzed children with refractory or relapsed high-risk neuroblastoma who were treated with high-dose131I-metaiodobenzylguanidine at Kanazawa University Hospital. They showed that within a 5-year period, this therapy could provide a favorable prognosis without severe non-hematological side effects. These findings could provide new insights into a novel treatment option for patients with high-risk neuroblastoma. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 19, 2020 Category: Cancer & Oncology Source Type: news
Neuroblastoma: Overview Video Neuroblastoma: Overview Video
This video covers key aspects of neuroblastoma, including the causes, symptoms, diagnosis, and treatment.Osmosis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 27, 2020 Category: Consumer Health News Tags: Med Students Commentary Source Type: news
Rice University bioscientist Rosa Uribe wins NSF CAREER Award
(Rice University) Rice University neurodevelopmental biologist Rosa Uribe has won a prestigious CAREER Award from the National Science Foundation to study neural crest cells, specialist stem cells that form the enteric nervous system and also cause neuroblastoma, the third most prevalent form of pediatric cancer in the U.S. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - February 18, 2020 Category: Biology Source Type: news
Dynamic interactions of the 5-HT6 receptor with protein partners control dendritic tree morphogenesis
This study highlights the complex allosteric modulation of GPCRs by protein partners and demonstrates how dynamic interactions between GPCRs and their protein partners can control the different steps of highly coordinated cellular processes, such as dendritic tree morphogenesis. (Source: Signal Transduction Knowledge Environment)
Source: Signal Transduction Knowledge Environment - February 10, 2020 Category: Science Authors: Pujol, C. N., Dupuy, V., Seveno, M., Runtz, L., Bockaert, J., Marin, P., Chaumont-Dubel, S. Tags: STKE Research Articles Source Type: news
New method for monitoring residual disease after treatment in children with neuroblastoma
(Kobe University) Neuroblastoma is a cancer that affects children, characterized by solid tumors that develop from immature nerve cells. Over 50% of patients with high-risk neuroblastoma experience tumor relapse/regrowth.A research group led by Professor NISHIMURA Noriyuki (Graduate School of Health Sciences, Kobe University) has developed a new method to monitor the residual disease after treatment in high-risk neuroblastoma patients. The method could be utilized to evaluate treatment response and facilitate early diagnosis of tumor relapse/regrowth. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 6, 2020 Category: Cancer & Oncology Source Type: news
Boy, six, visited his GP 11 TIMES before diagnosis of the 'largest tumour medics had ever seen'
Ellis Edwards, from Bournemouth, has stage four aggressive neuroblastoma. It was missed on successive trips to the doctors when his parents worried about his weight loss. (Source: the Mail online | Health)
Source: the Mail online | Health - February 4, 2020 Category: Consumer Health News Source Type: news
Smart algorithm finds possible future treatment for childhood cancer
(Uppsala University) Using a computer algorithm, scientists at Uppsala University have identified a promising new treatment for neuroblastoma. This form of cancer in children, which occurs in specialised nerve cells in the sympathetic nervous system, may be life-threatening. In the long term the discovery, described in the latest issue of the scientific journal Nature Communications, may result in a new form of treatment for children in whom the disease is severe or at an advanced stage. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 7, 2020 Category: Cancer & Oncology Source Type: news
Research sheds important light on the metastasis of neuroblastoma
(Children's Cancer Institute Australia) Research sheds important light on the metastasis of neuroblastoma. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 10, 2019 Category: Cancer & Oncology Source Type: news
Mother shares heartbreaking photo of her toddler undergoing cancer treatment
Sophia Soto, now six, from Florida, was diagnosed with neuroblastoma - a cancer which forms in nerve tissue - at just 14-months-old after tumors were found behind her eyes and on her kidney. (Source: the Mail online | Health)
Source: the Mail online | Health - November 28, 2019 Category: Consumer Health News Source Type: news
A step forward in the struggle against neuroblastoma, a type of childhood cancer
(University of Seville) A protein called CD44 makes it possible to identify the population of mother cells that are responsible for the aggressive nature and low survival rate of neuroblastoma, a type of childhood cancer that mainly affects children of two and three years old. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 27, 2019 Category: Cancer & Oncology Source Type: news
More children survive neuroblastoma
(Princess Máxima Center for Pediatric Oncology) Both the survival rate and the incidence of neuroblastoma have increased in the last decennia in the Netherlands, as was shown by a study from the Princess M á xima Center. The improved chance of survival and the increase in the number of patients has been greatest in the high risk group; children older than 18 months with a stage 4 neuroblastoma. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 18, 2019 Category: Cancer & Oncology Source Type: news
Researchers find new way to target childhood cancer
(Children's Cancer Institute Australia) An Australian-led international research effort has broken fresh ground in the race to find more effective treatments for the childhood cancer neuroblastoma, by uncovering a new and as-yet unexploited target in cancer cells that therapeutic drugs can be aimed at. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 12, 2019 Category: Cancer & Oncology Source Type: news
